Shanghai Pharmaceuticals Holding Co Ltd (601607) — Free Cash Flow Generation Index
Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Free Cash Flow Generation Index of 0.69x as of September 2025. Free cash flow of CN¥1.07 Billion represents 1% of operating cash flow (CN¥1.56 Billion). Explore 601607 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanghai Pharmaceuticals Holding Co Ltd Free Cash Flow Generation Index (1999–2025)
Historical FCF Generation Index trend for Shanghai Pharmaceuticals Holding Co Ltd across 27 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Shanghai Pharmaceuticals Holding Co Ltd.
Annual Free Cash Flow Generation for Shanghai Pharmaceuticals Holding Co Ltd (1999–2025)
Year-by-year Free Cash Flow Generation Index for Shanghai Pharmaceuticals Holding Co Ltd. Check Shanghai Pharmaceuticals Holding Co Ltd (601607) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.62x | CN¥3.83 Billion | CN¥6.15 Billion | CN¥2.33 Billion | ▲ +5.8% |
| 2024 | 0.59x | CN¥3.43 Billion | CN¥5.83 Billion | CN¥2.40 Billion | ▲ +36.1% |
| 2023 | 0.43x | CN¥2.26 Billion | CN¥5.23 Billion | CN¥2.97 Billion | ▼ -0.4% |
| 2022 | 0.43x | CN¥2.06 Billion | CN¥4.74 Billion | CN¥2.68 Billion | ▲ +133.0% |
| 2021 | 0.19x | CN¥942.55 Million | CN¥5.06 Billion | CN¥4.12 Billion | ▼ -66.8% |
| 2020 | 0.56x | CN¥3.83 Billion | CN¥6.84 Billion | CN¥3.01 Billion | ▲ +3.2% |
| 2019 | 0.54x | CN¥3.27 Billion | CN¥6.02 Billion | CN¥2.75 Billion | ▲ +42.8% |
| 2018 | 0.38x | CN¥1.19 Billion | CN¥3.14 Billion | CN¥1.94 Billion | ▲ +57.0% |
| 2017 | 0.24x | CN¥641.54 Million | CN¥2.65 Billion | CN¥2.01 Billion | ▲ +373.1% |
| 2016 | -0.09x | CN¥-172.62 Million | CN¥1.95 Billion | CN¥2.12 Billion | ▲ +67.8% |
| 2015 | -0.28x | CN¥-371.30 Million | CN¥1.35 Billion | CN¥1.72 Billion | ▼ -932.0% |
| 2014 | 0.03x | CN¥44.18 Million | CN¥1.34 Billion | CN¥1.29 Billion | ▼ -52.9% |
| 2013 | 0.07x | CN¥68.39 Million | CN¥973.45 Million | CN¥905.06 Million | ▼ -81.7% |
| 2012 | 0.38x | CN¥441.87 Million | CN¥1.15 Billion | CN¥708.91 Million | ▼ -49.9% |
| 2011 | 0.77x | CN¥1.36 Billion | CN¥1.77 Billion | CN¥413.54 Million | ▲ +13.8% |
| 2010 | 0.67x | CN¥1.14 Billion | CN¥1.69 Billion | CN¥550.30 Million | ▼ -23.4% |
| 2009 | 0.88x | CN¥584.17 Million | CN¥664.13 Million | CN¥79.97 Million | ▲ +28.7% |
| 2008 | 0.68x | CN¥195.18 Million | CN¥285.68 Million | CN¥90.50 Million | ▲ +12.6% |
| 2007 | 0.61x | CN¥296.66 Million | CN¥488.94 Million | CN¥192.29 Million | ▼ -18.0% |
| 2006 | 0.74x | CN¥431.51 Million | CN¥583.11 Million | CN¥151.60 Million | ▲ +143.2% |
| 2005 | -1.71x | CN¥-125.09 Million | CN¥73.00 Million | CN¥198.09 Million | ▲ +45.2% |
| 2004 | -3.13x | CN¥-192.72 Million | CN¥61.66 Million | CN¥254.38 Million | ▲ +99.1% |
| 2003 | -349.18x | CN¥-169.10 Million | CN¥484.27K | CN¥169.58 Million | ▼ -19616.5% |
| 2002 | -1.77x | CN¥-178.59 Million | CN¥100.84 Million | CN¥279.44 Million | ▼ -47.4% |
| 2001 | -1.20x | CN¥-78.97 Million | CN¥65.73 Million | CN¥144.71 Million | ▼ -3520.7% |
| 2000 | 0.04x | CN¥5.14 Million | CN¥146.22 Million | CN¥141.09 Million | ▼ -94.8% |
| 1999 | 0.68x | CN¥112.20 Million | CN¥164.67 Million | CN¥52.48 Million | — |